iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://pubmed.ncbi.nlm.nih.gov/26285587/
Direct oral anticoagulants (DOACs) - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec;20(6):575-7.
doi: 10.1177/1358863X15600256. Epub 2015 Aug 18.

Direct oral anticoagulants (DOACs)

Affiliations
Free article

Direct oral anticoagulants (DOACs)

Sara Vazquez et al. Vasc Med. 2015 Dec.
Free article

Abstract

DOACs are a new group of blood-thinner medications that may have some advantages over warfarin. A health care provider will look at several different factors to help patients decide if a DOAC is a good choice. Patients taking DOACs should discuss medication changes, a plan for taking the DOAC before and after a surgery, and any bleeding side effects with their health care provider.

Keywords: DVT; anticoagulants; apixaban; dabigatran; edoxaban; pulmonary embolism; rivaroxaban; thrombosis.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources